170399 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving growth factors
Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients
#302Molecules and methods for treatment and detection of cancer
#303Method for treatment or prevention of disease associated with functional disorder of regulatory T cell
#304PLGF, FLT1 AND ENDOGLIN FOR DIAGNOSING ANGIOGENIC STATUS IN CORONARY ARTERY DISEASE
#305SYSTEM TO ASSESS THE BIOLOGICAL ACTIVITY OF CHEMOATTRACTANTS
#306PlGF-1 assay and kits and components thereof
#307Diagnostic marker for diabetic vascular complications
#308HUMAN VASCULAR IBP-LIKE GROWTH FACTOR
#309Compounds Modulating Vegf Receptor and Uses Thereof
#310Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders
#311POLYPEPTIDE HAVING ANTI-ANGIOGENIC ACTIVITY
#312Differentiating ES cells using a tenascin
#313Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene
#314METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE DETECTION OF MOLECULES
#315Polynucleotides encoding myostatin binding agents
#316METHODS OF DETERMINING SKELETAL MATURITY
#317Saposin D and FAM3C are biomarkers for alzheimer's disease
#318Screening For Anti-Cancer Compounds Using Netrin-1 Activity
#319Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
#320Binding agents which inhibit myostatin
#321Methods and Devices for Rapid Assessment of Severity of Injury
#322METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#323Determination of sFlt-1:angiogenic factor complex
#324Methods for inhibiting VEGF-D
#325Methods of donor specific crossmatching
#326Anti-VEGF antibodies
#327METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#328Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV
#329Modular point-of-care devices, systems, and uses thereof
#330Method, compositions and classification for tumor diagnostics and treatment
#331Diagnostic methods
#332Natriuretic peptides and placenta growth factor levels for risk stratification
#333Biomarkers For Anti-Nogo-A Antibody Treatment in Spinal Cord Injury
#334Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
#335Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
#336Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin
#337Methods of culturing dermal papilla cells
#338Heregulin-like Factor
#339ELISA for VEGF
#340Treatments for pancreatic cancer metastases
#341The Use of Granulin-Epithelin Precursor (GEP) Anitbodies for Detection and Suppression of Hepatocellular Carcinoma (HCC)
#342Methods of dignosing or treating depression on basis of increased cerebrospinal fluid levels of neurotrodhin 3
#343Method for the diagnosis of chronic stress and related disorders
#344Cyclin-dependent kinase inhibitors as targets for opiod growth factor treatment
#345Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
#346Analysis of insulin-like growth factors from biological fluids by the use of affinity-based mass spectrometric methods
#347Human Vascular IBP-Like Growth Factor
#348Method For Monitoring The Progress Of Cancer
#349METHODS OF TREATING PSYCHOSIS AND SCHIZPHRENIA BASED ON POLYMORPHISMS IN THE CNTF GENE
#350Test System for the Discovery of Substances for the Promotion of Neuraxonal Growth
#351Method and Composition for Thickening Hair
#352Methods of determining skeletal maturity
#353METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#354GDF-9/BMP-15 modulators for the treatment of bone disorders
#355Systems and methods for screening for modulators of neural differentiation
#356ELISA for VEGF
#357Detecting and predicting pre-eclampsia
#358Methods for prediction and prognosis of cancer, and monitoring cancer therapy
#359Methods and compositions for diagnosing and suppressing metastasis thereof
#360SALIVARY PROTEIN AND RNA FOR BREAST CANCER DETECTION
#361Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#362Antagonist antibodies against GDF-8
#363Method of determining cytokine dosage for improving myelosuppressive state
#364Compositions and methods of mutant Nogo-66 domain proteins
#365Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
#366Method of determining cytokine dosage for myelosuppressive state
#367Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
#368Method, compositions and classification for tumor diagnostics and treatment
#369Heregulin-like factor
#370RAG polypeptides, nucleic acids, and their use
#371Method of evaluating myelosuppressive state
#372Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
#373MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
#374Netrin compositions and methods of using the same
#375MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
#376Method for treating cancer and increasing hematocrit levels
#377Carboline derivatives useful in the treatment of cancer
#378Methods and compositions for activating VEGF-D and VEGF-C
#379Treatments for cancer
#380Methods of modulating hair growth
#381Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
#382Methods of donor specific crossmatching
#383Compositions and methods for diagnosing and treating autoimmune disease
#384Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
#385Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway
#386Diagnosis of lysosomal storage disorders using saposins and other markers
#387Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell factor
#388Human vascular IBP-like growth factor
#389Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene
#390VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
#391Analysis of insulin-like growth factors from biological fluids by the use of affinity-based mass spectrometric methods
#392Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof